Tests an olive leaf extract in adults with type 2 diabetes
Tests an olive leaf extract, Atherolive, against a placebo in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Olive Leaf Extracts in the Control of Diabet
Key facts
- Where
- Monastir, TunisiaSee the site
- Phase
- Phase 2/3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT05605704, who can take part
Where in Tunisia
- Semir NouiraMonastir, TunisiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Monastir
- Trial code
- NCT05605704
- Record updated
- 3 June 2025
- Original description
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital).Read full original descriptionShow less
Efficacy of a Treatment Based on Olive Leaf Extracts in the Control of Diabet
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital).
Patients over 18 years of age with:
-Diabets
Inclusion: Patients over 18 years of age with:; diabetes.
Exclusion: Exclusion criteria: None.